Ankerstar Wealth’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$301 Hold
12
– – ﹤0.01% 837
2026
Q2
$304 Hold
12
– – ﹤0.01% 795
2026
Q1
$271 Buy
12
+7
+140% +$156 ﹤0.01% 787
2025
Q4
$129 Buy
+5
New +$119 ﹤0.01% 972

Other funds holding PCRX

Ankerstar Wealth's PCRX Position: Q3 2026 in Review

Ankerstar Wealth held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 12 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #837.

Ankerstar Wealth first reported a position in PCRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $304 in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.

  • Ankerstar Wealth held 12 shares of Pacira BioSciences worth $301 as of Q3 2026.
  • Ankerstar Wealth left its Pacira BioSciences share count unchanged in Q3 2026.
  • Pacira BioSciences made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #837 holding.
  • Ankerstar Wealth first reported a position in Pacira BioSciences in Q4 2025 and has held it in 4 quarters since.
  • Ankerstar Wealth's Pacira BioSciences position peaked at $304 in Q2 2026.
  • 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.

Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.